NCT00477685View on ClinicalTrials.gov

Ologen (OculusGen)-Phacotrabeculectomy Historical Control Study in India

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
GlaucomaCataract
Interventions
DEVICE

OculusGen Biodegradable Collagen Matrix Implant

OculusGen Biodegradable Collagen Matrix Implant in Trabeculectomy.

Trial Locations (1)

500 034

Grewal Eye Institute, Chandigarh

All Listed Sponsors
lead

Pro Top & Mediking Company Limited

INDUSTRY

NCT00477685 - Ologen (OculusGen)-Phacotrabeculectomy Historical Control Study in India | Biotech Hunter | Biotech Hunter